In agreement with NRP1 antagonism, NRP1 silencing with two individual specific siRNAs in lung carcinoma A549 cells decreased cell viability and increased the cytotoxic effects of both 5-FU and paclitaxel as compared with that in control siRNA-transfected cells (Figure 4H). This evidence concerns the gene NRP1 and lung carcinoma.